Product logins

Find logins to all Clarivate products below.


Varicose Vein Treatment Devices – Market Insights – Europe (Supplemental)

Although the COVID-19 global pandemic has negatively impacted the European varicose vein treatment device market in the short term, the market has largely recovered and will grow moderately over the remainder of the forecast period, supported by a shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely ERFA and ELA, which will compete with surgical stripping procedures.

This Medtech 360 Report provides high-level market metrics for varicose vein treatment device market in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2031.

Table of contents


Related Medtech Insights Reports

Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative higher-priced powered thrombectomy devices, together with the increasing use of PE treatment procedures—both supported by favorable clinical data—will drive strong…
Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Neurovascular Devices – Market Insights – Europe
The European neurovascular device market is poised to experience strong growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…